Literature DB >> 10959761

Respiratory syncytial virus vaccines: recent developments.

P A Piedra1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10959761     DOI： 10.1097/00006454-200008000-00035

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  2 in total

1.  Characteristics of immunity induced by viral antigen or conferred by antibody via different administration routes.

Authors:  T Matsuoka; Y Okamoto; Z Matsuzaki; S Endo; E Ito; H Tsutsumi; R A Williamson; H Sakurai; D R Burton; I Saito
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

2.  Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection.

Authors:  Thierry Lacaze-Masmonteil; Juergen Seidenberg; Ian Mitchell; Veerle Cossey; Martin Cihar; Michal Csader; Rienk Baarsma; Marques Valido; Paul F Pollack; Jessie R Groothuis
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.